Skip to main content
Newron Pharmaceuticals S.p.A. (NWPHF)
OTCMKTS · Delayed Price · Currency is USD
12.00
+0.60 (5.26%)
May 15, 2024, 9:30 AM EDT

Newron Pharmaceuticals Revenue

In the year 2024, Newron Pharmaceuticals had annual revenue of 51.39M EUR with 467.41% growth. Newron Pharmaceuticals had revenue of 47.98M in the half year ending December 31, 2024, with 1,370.07% growth.

Revenue
51.39M EUR
Revenue Growth
+467.41%
P/S Ratio
3.26
Revenue / Employee
2.34M EUR
Employees
22
Market Cap
173.70M USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202451.39M42.33M467.41%
Dec 31, 20239.06M2.96M48.62%
Dec 31, 20226.09M332.00K5.76%
Dec 31, 20215.76M504.00K9.59%
Dec 31, 20205.26M-1.78M-25.29%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo, Inc. 1.73B
Veradigm 588.02M
Elite Pharmaceuticals 70.00M
Tian'an Technology Group 1.78M
American Oncology Network 1.76B
Glass House Brands 215.62M
Northwest Biotherapeutics 1.47M
Silence Therapeutics 27.70M
Revenue Rankings

Newron Pharmaceuticals News

More News